Petmed Express Inc Revenue Growth Rates (PETS), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Petmed Express Inc   (NASDAQ: PETS)
 

PETS's Revenue Growth by Quarter and Year

Petmed Express Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/PETS/growth
https://api.csimarket.com/api/v1/companies/PETS/fundamentals
https://api.csimarket.com/api/v1/companies/PETS/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
PETS Revenue (in millions $) FY 2027 FY 2026 FY 2025 FY 2024
4th Quarter March -
3rd Quarter December -
2nd Quarter September 35.77
1st Quarter June 41.02
FY 76.79

PETSs Annual Revenue
Petmed Express Inc 's Revenue in the fiscal year 2026 $ 52.22 millions
Petmed Express Inc 's Revenue in the fiscal year 2025 $ 226.14 millions
Petmed Express Inc 's Revenue in the fiscal year 2024 $ 280.65 millions
Petmed Express Inc 's Revenue in the fiscal year 2023 $ 255.74 millions
Petmed Express Inc 's Revenue in the fiscal year 2022 $ 273.42 millions




PETS Revenue second quarter 2027 Y/Y Growth Comment
Petmed Express Inc reported decline in Revenue in the second quarter 2027 by -17.62% to $ 35.77 millions, from the same quarter in 2026.
The contraction in the second quarter 2027 Petmed Express Inc 's Revenue compares unfavorably to the Company's average Revenue decrease of -2.42%.

Looking into second quarter 2027 results within Pharmacy Services & Retail Drugstore industry 9 other companies have achieved higher Revenue growth. While Petmed Express Inc ' s Revenue fall of -17.62% ranks overall at the positon no. 3568 in the second quarter 2027.


PETS Revenue ( Y/Y Growth %) 2027
 FY 2026 FY 2025 FY 2024
4th Quarter March -
3rd Quarter December -
2nd Quarter September -17.62 %
1st Quarter June -18.61 %
FY   -

Financial Statements
Petmed Express Inc 's second quarter 2027 Revenue $ 35.77 millions PETS's Income Statement
Petmed Express Inc 's second quarter 2026 Revenue $ 43.42 millions Quarterly PETS's Income Statement


PETS Revenue (Quarter on Quarter Growth %)

 2027
 FY 2026 FY 2025 FY 2024
4th Quarter March -
3rd Quarter December -
2nd Quarter September -12.8 %
1st Quarter June -4.2 %
FY (Year on Year)   -


Back to PETS Growth rate Comparisons >> Back to PETS Growth rate Comparisons >>


Revenue second quarter 2027 Y/Y Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry #10
Retail Sector #174
Overall #3568

Revenue Y/Y Growth Statistics
High Average Low
20.27 % -2.42 % -78.35 %
(Dec 31 2020)   (Dec 31 2025)
Revenue second quarter 2027 Y/Y Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry #10
Retail Sector #174
Overall #3568
Revenue Y/Y Growth Statistics
High Average Low
20.27 % -2.42 % -78.35 %
(Dec 31 2020)   (Dec 31 2025)

Revenue by Quarter for the Fiscal Years 2024, 2025, 2026, 2027

Petmed Express Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
273.75 % 1.43 % -100 %
(Mar 31 2026)  


PETS's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2027 Petmed Express Inc disclosed drop in Revenue from the first quarter by -12.8% to $ 35.77 millions, from $ 41.02 millions achived in the previous reporting period.

But that's not important problem, as Petmed Express Inc 's Revenue generally seem to plunge in this quarter.

Within Pharmacy Services & Retail Drugstore industry 2 other companies have achieved higher Revenue quarter on quarter growth. While Petmed Express Inc 's Revenue growth quarter on quarter, overall rank is 2371.


Revenue Q/Q Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry #3
Retail Sector #82
Overall #2371
Revenue Q/Q Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry #3
Retail Sector #82
Overall #2371
Revenue Q/Q Growth Statistics
High Average Low
273.75 % 1.43 % -100 %
(Mar 31 2026)  


PETS's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2027 Petmed Express Inc disclosed drop in Revenue from the first quarter by -12.8% to $ 35.77 millions, from $ 41.02 millions achived in the previous reporting period.

But that's not important problem, as Petmed Express Inc 's Revenue generally seem to plunge in this quarter.

Within Pharmacy Services & Retail Drugstore industry 2 other companies have achieved higher Revenue quarter on quarter growth. While Petmed Express Inc 's Revenue growth quarter on quarter, overall rank is 2371.


Petmed Express Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2026)		 12 Months Ending (Jun 30 2026) 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025)
Cumulative Revenue 12 Months Ending $ 131.06
Y / Y Revenue Growth (TTM) -32.33 %
Year on Year Revenue Growth Overall Ranking # 3384
Seqeuential Revenue Change (TTM) -5.51 %
Seq. Revenue Growth (TTM) Overall Ranking # 3053


Cumulative Revenue growth Comment
Petmed Express Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Jun 30 2026. If the fiscal year would end in Sep 30 2026, Petmed Express Inc 's annual Revenue decline would be -32.33% year on year to $131 millions.

In the Retail sector 161 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 3035 to 3384.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry # 8
Retail Sector # 162
Overall # 3384

Revenue TTM Y/Y Growth Statistics
High Average Low
13.64 %
 -2.15 %
-38.46 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 8
Sector # 143
S&P 500 # 3053
Cumulative Revenue growth Comment
Petmed Express Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Jun 30 2026. If the fiscal year would end in Sep 30 2026, Petmed Express Inc 's annual Revenue drop would be -32.33% year on year to $131 millions.

In the Retail sector 161 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 3035 to 3384.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry # 8
Retail Sector # 162
Overall # 3384

Revenue TTM Y/Y Growth Statistics
High Average Low
13.64 %
-2.15 %
-38.46 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 8
Sector # 143
S&P 500 # 3053




Other Revenue Growth
Pharmacy Services & Retail Drugstore Industry Revenue Growth Trends and Statistics
Retail Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
PETS's Revenue Growth Ratio versus Pharmacy Services & Retail Drugstore Industry, Retail Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue drop for the quarter ending Sep 30 2026 within Retail SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Albertsons Companies Inc -0.11%$ -0.110 millions
Autonation Inc -0.39%$ -0.385 millions
Guardian Pharmacy Services Inc -1.68%$ -1.684 millions
Builders Firstsource Inc -2.19%$ -2.194 millions
Hour Loop Inc -3.32%$ -3.316 millions
Growgeneration Corp -4.42%$ -4.424 millions
Group 1 Automotive Inc-6.68%$ -6.675 millions
Asbury Automotive Group Inc -8.07%$ -8.067 millions
The Honest Company Inc -8.52%$ -8.516 millions
Camping World Holdings Inc -12.36%$ -12.358 millions
Nu Skin Enterprises Inc -14.49%$ -14.493 millions
Grove Collaborative Holdings Inc -15.81%$ -15.807 millions
Petmed Express Inc -17.61%$ -17.609 millions
Bark Inc -18.13%$ -18.135 millions
Latch Inc -18.86%$ -18.857 millions
1 800 Flowers Com Inc-20.21%$ -20.214 millions
The Beachbody Company Inc -24.25%$ -24.249 millions
Monro Inc -40.25%$ -40.251 millions
Weis Markets inc-41.22%$ -41.216 millions
Crown Equity Holdings Inc -63.44%$ -63.441 millions
Vroom Inc -96.18%$ -96.179 millions


About Petmed Express Inc Revenue Growth Rates (PETS), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Petmed Express Inc (CIK 1040130).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001040130-26-000071
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Petmed Express Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.